COVID-19 mRNA Vaccine and Myocarditis
- PMID: 34268277
- PMCID: PMC8276934
- DOI: 10.12890/2021_002681
COVID-19 mRNA Vaccine and Myocarditis
Abstract
Coronavirus disease 2019 (COVID-19) is believed to have originated in the Hua nan South China Seafood Market in Wuhan and can present with a spectrum of clinical manifestations. We report the case of 24-year-old male patient who developed chest pain after administration of the second dose of the Pfizer-BioNTech mRNA COVID-19 vaccine and who was diagnosed with myocarditis on work-up.
Learning points: Localized injection site reactions and systemic adverse effects can occur after administration of the various COVID-19 vaccines.Healthcare providers should maintain a high index of suspicion regarding myocarditis after mRNA COVID-19 vaccination in the appropriate clinical scenario.
Keywords: COVID-19; COVID-19 vaccine; SARS-CoV-2; adverse events; inflammation of the heart; myocarditis; pericarditis; severe acute respiratory syndrome coronavirus 2; side effects.
© EFIM 2021.
Conflict of interest statement
Conflicts of Interests: The authors declare there are no competing interests.
Figures
References
-
- Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss H-P, McCarthy R, et al. Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol. 2003;42(3):466–472. - PubMed
-
- Halsell JS, Riddle JR, Atwood JE, Gardner P, Shope R, Poland GA, et al. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA. 2003;289(24):3283–3289. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous